2. Signaling Pathways
  3. Immunology/Inflammation
  4. NO Synthase
  5. NO Synthase Antagonist

NO Synthase Antagonist

NO Synthase Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-141411A
    Zevaquenabant
    		Antagonist
    Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual cannabinoid CB1 receptor and inducible NOS antagonist. Zevaquenabant ameliorates obesity-induced chronic kidney disease (CKD).